Trading IdeasFundamentals

Sudarshan Pharma Industries LI

BSE: SUDARSHAN · Specialty Chemicals · sector

₹31.99BSE close 2026-10-26

Key numbers

Market cap₹799 cr
Price₹31.99
52w high / low₹43 / ₹18
P/E26.2xSector median 22.6x
P/B5.2xSector median 2.6x
Book value₹6.2
Dividend yield–Sector median 0.60%
ROE22.8%Sector median 10.6%
ROCE16.4%Sector median 12.9%
OPM7.5%Sector median 12.1%
Debt / equity1.83xSector median 0.18x
EV/EBITDA16.1xSector median 15.1x
Interest cover2.1x
Current ratio1.07x
Sales growth 3y+15.1%Sector median +5.0%
Profit growth 3y+49.0%Sector median +0.9%
PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹48.80 · low ₹19.70
Nov 2024May 2025Nov 2025May 2026Oct 2026

Quarterly results

₹ crMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue277145169168389174
EBITDA22119113116
OPM %7.8%7.6%5.4%6.5%8.0%9.1%
Other income112261
Net profit10444156
EPS (₹)0.410.160.160.180.650.23
Revenue YoY+40.3%+20.1%
Profit YoY+51.4%+45.4%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY23FY24FY25FY26TTM
Revenue461466505703900
EBITDA1523375167
Net profit711162329
EPS (₹)5.484.720.660.971.22
Revenue growth+0.9%+8.5%+39.2%–
Profit growth+61.4%+39.8%+46.7%–
Dividend / share (₹)–0.30––
Compounded growth3 years5 yearsLast 12 months
Sales+15.1%––
Net profit+49.0%––
EPS-43.9%––
Share price–-1.2% (2y)+22.2%

Balance sheet

₹ crFY25FY26
Shareholders' equity104155
Borrowings–283
Cash & equivalents21
Total assets402642
Fixed assets2077
Capital work in progress–3
Investments290
Receivables–233
Inventory140219
Payables–188

Year-end figures from the March annual filing.

Cash flow

₹ crFY25FY26
Cash from operations-26-2
Cash from investing-20-78
Cash from financing4781
Capex169
Free cash flow-27-71

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY25FY26
ROE %15.3%15.0%
ROCE %36.1%12.8%
Debtor days–121
Inventory days117129
Payable days–111
Cash conversion cycle (days)–139
Working capital days5418

Peers in Specialty Chemicals

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
PIDILITIND₹1,50,431 cr56.8x13.9x25.7%33.4%24.5%+7.4%1.01%
FLUOROCHEM₹46,168 cr75.4x5.9x8.1%10.0%25.6%-4.2%0.07%
NAVINFLUOR₹39,306 cr49.7x9.9x23.9%22.2%33.7%+16.8%0.18%
DEEPAKNTR₹19,676 cr25.1x3.4x14.0%15.3%15.4%-0.4%0.52%
AETHER₹19,529 cr82.8x8.0x10.1%11.4%30.9%+21.2%–
ATUL₹15,762 cr19.8x2.5x11.9%16.9%17.9%+7.9%0.47%
AARTIIND₹15,539 cr29.3x2.6x9.2%8.0%14.9%+7.8%0.24%
FINEORG₹15,328 cr35.0x5.8x17.7%21.3%21.7%-7.8%0.22%
BASF₹13,174 cr20.5x3.3x16.9%22.0%5.9%+3.1%0.66%
SUDARSHAN₹799 cr26.2x5.2x22.8%16.4%7.5%+15.1%–

All 107 companies in Specialty Chemicals →

Dividends & corporate actions

Ex-dateActionDetail
2023-08-25DividendFinal Dividend Rs 0.3

Documents

Links go to the original files on the exchange website.

About the company

SectorCommodities
IndustrySpecialty Chemicals
Sub-industrySpecialty Chemicals
SymbolSUDARSHAN
BSE code543828
ISININE00TV01023
Face value₹1.0
Incorporated–
Website–
Plants (India / abroad)–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.